Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/ys-biopharma-announces-unaudited-financial-results-for-the-first-nine-months-of-fiscal-year-2024-302121952.html
https://www.prnewswire.com/news-releases/ys-biopharma-granted-phase-i-clinical-trial-license-of-therapeutic-chronic-hepatitis-b-virus-vaccine-302120805.html
https://www.fiercebiotech.com/biotech/ys-biopharmas-rabies-vaccine-bests-approved-competitor-interim-phase-3-readout
https://www.prnewswire.com/news-releases/ys-biopharma-announces-positive-interim-results-of-pivotal-phase-3-clinical-study-of-pika-rabies-vaccine-302111651.html
https://www.prnewswire.com/news-releases/ys-biopharma-announces-full-repayment-of-us40-000-000-loan-facility-302107132.html
https://www.prnewswire.com/news-releases/ys-biopharma-announces-board-changes-and-strategic-leadership-appointments-in-chinese-subsidiaries-302079837.html
https://www.prnewswire.com/news-releases/noble-capital-markets-initiates-coverage-on-ys-biopharma-with-outperform-rating-and-us5-25-price-target-301987487.html
https://www.prnewswire.com/news-releases/ys-biopharma-announces-first-subject-enrollment-in-pivotal-phase-3-clinical-trial-of-pika-rabies-vaccine-301938632.html
https://www.prnewswire.com/news-releases/yishengbio-received-approvals-from-philippines-and-uae-for-phase-2--3-clinical-trials-of-pika-recombinant-covid-19-vaccine-301620459.html